Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-09 Purchase | 2023-06-13 4:41 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 511 | $3.42 | $1,748 | 1,262 (Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 5:17 pm | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Accounting Officer | 955 | $1.57 | $1,499 | 9,004 (Direct) | View |
| 2020-12-10 Purchase | 2020-12-14 4:12 pm | Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO | 5,095 | $2.278 | $11,606 | 8,049 (Direct) | View |
| 2020-06-10 Purchase | 2020-06-11 9:08 pm | Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO | 2,954 | $2.278 | $6,729 | 2,954 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-13 Option Award | 2024-08-14 4:11 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 259,300 | $0 | 259,306 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-17 07:44 am | 2024-05-15 2033-05-15 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:19 pm | N/A 2033-02-13 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-10-05 Option Award | 2022-10-07 4:01 pm | 2023-10-05 2032-10-05 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-10 5:50 pm | N/A 2032-03-08 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-28 4:08 pm | N/A 2031-01-26 | Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2020-05-04 4:50 pm | N/A 2028-04-30 | Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO | 0 | $0 | 180,000 (Direct) | View |